华仁药业：股东华仁世纪集团拟减持不超过总股本3%的股份

Core Viewpoint - Huaren Pharmaceutical (300110.SZ) announced that its major shareholder, Huaren Century Group, plans to reduce its stake by up to 3% of the total share capital, equivalent to no more than 35.46 million shares, due to operational needs [1] Summary by Category Shareholder Actions - Huaren Century Group, holding over 5% of the shares, intends to reduce its holdings through centralized bidding and block trading methods within three months after the announcement [1] - The reduction will not exceed 3% of the total share capital, which translates to a maximum of 35.46 million shares [1] Reasons for Reduction - The primary reason for the share reduction is the operational needs of Huaren Century Group [1]